Pulmonary pathology of severe acute respiratory syndrome in Toronto

Cited by (331)

Items 101–200 of 331

  1. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients
    Dickson W.L. Wong, Barbara M. Klinkhammer, Sonja Djudjaj, Sophia Villwock, M. Cherelle Timm, Eva Miriam Buhl, Sophie Wucherpfennig, Claudio Cacchi, Till A. Braunschweig, Ruth Knüchel et al. · 2021 · Cells
  2. Alveolar cell fate selection and lifelong maintenance of AT2 cells by FGF signaling
    Douglas Brownfield, Alex Diaz de Arce, Elisa Ghelfi, Astrid Gillich, Tushar Desai, Mark A. Krasnow · 2022 · Nature Communications
  3. Immunobiotic lactobacilli reduce viral-associated pulmonary damage through the modulation of inflammation–coagulation interactions
    Hortensia Zelaya, Kohichiro Tsukida, Eriko Chiba, Gabriela Marranzino, Susana Alvarez, Haruki Kitazawa, Graciela Agüero, Julio Villena · 2014 · International Immunopharmacology
  4. Urgent reconsideration of lung edema as a preventable outcome in COVID-19: inhibition of TRPV4 represents a promising and feasible approach
    Wolfgang Michael Kuebler, Sven‐Eric Jordt, Wolfgang Liedtke · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  5. Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
    Frédéric Lamoth, Russell Edward Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis · 2021 · The Journal of Infectious Diseases
  6. The Severe Acute Respiratory Syndrome Coronavirus 3a Protein Up-Regulates Expression of Fibrinogen in Lung Epithelial Cells
    Yee‐Joo Tan, Puay-Yoke Tham, Daphne Z. L. Chan, Chih-Fong Chou, Shuo Shen, Burtram Clinton Fielding, Timothy H. P. Tan, Seng Gee Lim, Wanjin Hong · 2005 · Journal of Virology
  7. Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection
    Zachary Grimes, Clare Bryce, Emilia Mia Sordillo, Ronald E. Gordon, Jason Reidy, Alberto Paniz‐Mondolfi, Mary Elizabeth Fowkes · 2020 · Cardiovascular Pathology
  8. Pathological post‐mortem findings in lungs infected with SARS‐CoV‐2
    Stefania Damiani, Michelangelo Fiorentino, Alessandra De Palma, Maria Pia Foschini, Tiziana Lazzarotto, Liliana Gabrielli, P. Viale, Luciano Attard, Mattia Riefolo, Antonietta D’Errico · 2020 · The Journal of Pathology
  9. Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature
    Mariel Valdivia‐Mazeyra, Clara Salas, Jesús Nieves‐Alonso, Luz M. Martín-Fragueiro, Carmen Bárcena, Patricia Muñoz‐Hernández, Karen Villar Zarra, Javier Martín-López, Fernando Ramasco-Rueda, Javier Fraga et al. · 2020 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  10. Accuracy of galactomannan testing on tracheal aspirates in COVID‐19‐associated pulmonary aspergillosis
    Carla Marina Román-Montes, Areli Martínez‐Gamboa, Paulette Diaz‐Lomelí, Axel Cervantes Sánchez, Andrea Rangel‐Cordero, José Sifuentes‐Osornio, Alfredo Ponce‐de‐León, María Fernanda González-Lara · 2020 · Mycoses
  11. Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic
    Michael A. Matthay, Carolyn M. Hendrickson · 2013 · Seminars in Respiratory and Critical Care Medicine
  12. Altered Pathogenesis of Porcine Respiratory Coronavirus in Pigs due to Immunosuppressive Effects of Dexamethasone: Implications for Corticosteroid Use in Treatment of Severe Acute Respiratory Syndrome Coronavirus
    Kwonil Jung, Konstantin P. Alekseev, Xinsheng Zhang, Doo‐Sung Cheon, Anastasia Nickolaevna Vlasova, Linda J. Saif · 2007 · Journal of Virology
  13. Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus
    Yee‐Joo Tan, Seng Gee Lim, Wanjin Hong · 2006 · Antiviral Research
  14. Systemic Mycoses: A Potential Alert for Complications in COVID-19 Patients
    Gonzalo Segrelles‐Calvo, Glauber Ribeiro de Sousa Araújo, Susana Frasés · 2020 · Future Microbiology
  15. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia
    Zhe Liu, Chao Jin, Carol C. Wu, Ting Bo Liang, Huifang Zhao, Yan Wang, Zekun Wang, Fen Li, Jie Zhou, Shubo Cai et al. · 2020 · Korean Journal of Radiology
  16. Lipid profile as an indicator of COVID-19 severity: A systematic review and meta-analysis
    Roshan Kumar Mahat, Vedika Rathore, Neelima Singh, Nivedita Singh, Sanjeev Kumar Singh, Rakesh Kumar Shah, Chanchal Garg · 2021 · Clinical Nutrition ESPEN
  17. Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?
    Xiaoling Cao, Rong H. Yin, Helmut Albrecht, Daping Fan, Wenbin Tan · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  18. Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice
    Bing Han, Xue‐Zhong Ma, Jianhua Zhang, Yu Zhang, Xiaohui Bai, David M. Hwang, Shaf H Keshavjee, Gary A Levy, Ian D. McGilvray, Mingyao Liu · 2012 · Laboratory Investigation
  19. SARS Coronavirus and Lung Fibrosis
    Wei Zuo, Xingang Zhao, Ye‐Guang Chen · 2009 · Springer eBooks
  20. Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants
    Obinna Tobechukwu Ezeokoli, Onele M. N. Gcilitshana, Carolina Henritta Pohl · 2021 · Journal of Fungi
  21. How the SARS coronavirus causes disease: host or organism?
    Anthony W.I. Lo, Nelson L.S. Tang, Ka‐Fai To · 2005 · The Journal of Pathology
  22. Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
    Erica Villa, Rosina Maria Critelli, Simone Lasagni, Alessandra Melegari, Angela Curatolo, Ciro Celsa, Dante Romagnoli, Gabriele Melegari, Alessandra Pivetti, Lorenza Di Marco et al. · 2021 · Blood Advances
  23. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
    Luca Costanzo, Francesco Paolo Palumbo, Giorgio Ardita, Pier Luigi Antignani, Enrico Arosio, Giacomo Failla · 2020 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  24. Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS)
    Wai S Chan, Chun Fu Wu, Sammy C S Chow, To Cheung, Ka‐Fai To, Wai K. Leung, Paul K.S. Chan, Kam-Cheong Lee, Ho‐Keung Ng, D Au et al. · 2005 · Modern Pathology
  25. Different computed tomography patterns of Coronavirus Disease 2019 (COVID-19) between survivors and non-survivors
    Feng Pan, Chuansheng Zheng, Tianhe Ye, Lingli Li, Dehan Liu, Li Lin, Richard Lindsay Hesketh, Lian Yang · 2020 · Scientific Reports
  26. COVID-19 patients may become predisposed to pulmonary arterial hypertension
    Yuichiro Suzuki, Sofia I. Nikolaienko, Nataliia V. Shults, Sergiy G. Gychka · 2021 · Medical Hypotheses
  27. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
    Mirjam Kiener, Nuria Roldán, Carlos Machahua, Arunima Sengupta, Thomas Geiser, Olivier T. Guenat, Manuela Funke-Chambour, Nina Hobi, Marianna Kruithof‐de Julio · 2021 · Frontiers in Medicine
  28. Rare idiopathic interstitial pneumonias: LIP and PPFE and rare histologic patterns of interstitial pneumonias: AFOP and BPIP
    Maria A. Kokosi, Andrew Gordon Nicholson, David M. Hansell, Athol Umfrey Wells · 2015 · Respirology
  29. Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective
    Valentina Zappulli, Silvia Ferro, Federico Bonsembiante, Ginevra Brocca, Alessandro Calore, Laura Cavicchioli, Cinzia Centelleghe, Giorgia Corazzola, Steffen De Vreese, Maria Elena Gelain et al. · 2020 · Animals
  30. SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems
    Anne G. Savitt, Samantha Manimala, Tiara White, Marina Fandaros, Wei Yin, Huiquan Duan, Xin Xu, Brian V. Geisbrecht, David Alan Rubenstein, Allen P. Kaplan et al. · 2021 · Frontiers in Immunology
  31. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients
    Farahnaz Sadegh Beigee, Mihan Pourabdollah Toutkaboni, Neda Khalili, Seyed Alireza Nadji, Atosa Dorudinia, Mitra Sadat Rezaei, Elham Askari, Behrooz Farzanegan, Majid Marjani, Amir Rafiezadeh · 2020 · Pathology - Research and Practice
  32. Complement and coagulation: key triggers of COVID-19–induced multiorgan pathology
    Berhane Ghebrehiwet, Ellinor I.B. Peerschke · 2020 · Journal of Clinical Investigation
  33. Coagulation Disorders in COVID-19: Role of Toll-like Receptors
    Indranil Biswas, Gausal Azam Khan · 2020 · Journal of Inflammation Research
  34. Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns
    Jeroen A. Schouten, Jan J. De Waele, Christian Lanckohr, Despoina Koulenti, Nisrine Haddad, Nesrine Rizk, Fredrik Sjövall, Souha Sami Kanj · 2021 · International Journal of Antimicrobial Agents
  35. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS
    Ludmila Lupu, Annette Palmer, Markus Stefan Huber-Lang · 2020 · Frontiers in Immunology
  36. Machine learning‐based analysis of alveolar and vascular injury in SARS‐CoV ‐2 acute respiratory failure
    Fiorella Calabrese, Federica Pezzuto, Francesco Fortarezza, Annalisa Boscolo, Francesca Lunardi, Chiara Giraudo, Anna Maria Cattelan, Claudia Del Vecchio, Giulia Lorenzoni, Luca Vedovelli et al. · 2021 · The Journal of Pathology
  37. Acute Fibrinous and Organizing Pneumonia
    Hideo Kobayashi, Chikatoshi Sugimoto, Soichiro Kanoh, Kazuo Motoyoshi, Shinsuke Aida · 2005 · Journal of Thoracic Imaging
  38. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain
    Pedro Navarro Conde, P Alemany Monraval, Carmen Medina, Ana Jiménez Sánchez, Juan Carlos Andrés Teruel, José Ferrando Marco, Víctor Puglia Santos, Empar Mayordomo Aranda · 2020 · Revista Española de Patología
  39. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients
    Kerri Basile, Catriona L Halliday, Jen Kok, Sharon C.‐A. Chen · 2022 · Journal of Fungi
  40. Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction
    Naoto Yokogawa, David V. Alcid · 2007 · AIDS
  41. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic
    The COVID-19 Autopsy · 2020 · Revista Española de Patología
  42. Epidemiology of Systemic Mycoses in the COVID-19 Pandemic
    María Guadalupe Frías-De León, Rodolfo Pinto‐Almazán, Rigoberto Hernández‐Castro, Eduardo García-Salazar, Patricia A. Meza-Meneses, Carmen Rodríguez‐Cerdeira, Roberto Arenas, Esther Conde-Cuevas, Gustavo Acosta‐Altamirano, Erick Obed Martínez-Herrera · 2021 · Journal of Fungi
  43. COVID-19 associated pulmonary aspergillosis in ICU patients: Report of five cases from Argentina
    María Fernanda Benedetti, Katherine Hermida Alava, Judith Sagardía, Roberto Corella Cadena, Diego Laplume, Paula Capece, Gladys Posse, Alejandro David Nusblat, María L. Cuestas · 2020 · Medical Mycology Case Reports
  44. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19–Associated Coagulopathies
    Ethan S. FitzGerald, Yongzhi Chen, Katherine A. Fitzgerald, Amanda Mercedes Jamieson · 2021 · American Journal of Respiratory Cell and Molecular Biology
  45. Pathogenesis, Imaging, and Evolution of Acute Lung Injury
    Seth J. Kligerman · 2022 · Radiologic Clinics of North America
  46. Life after acute fibrinous and organizing pneumonia: a case report of a patient 30 months after diagnosis and review of the literature
    Catherine M. Kuza, Theofilos Matheos, Deirdre Kathman, Stephen O. Heard · 2015 · Journal of Critical Care
  47. Superinfections in COVID-19 Patients: Role of Antimicrobials
    Vijaya Lakshmi Nag, Navneet Kaur · 2021 · Dubai Medical Journal
  48. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities
    Woon Hean Chong, Biplab Kumar Saha, Amit Chopra · 2021 · Heart & Lung
  49. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study
    Manish Kumar Pandey, Alexander May, Laura Tan, Harriet C. Hughes, Jack Parry Jones, Wendy Harrison, Scott Bradburn, Sam Tyrrel, Babu Muthuswamy, Nidhika Berry et al. · 2022 · Critical Care
  50. A 64-Year-Old Male With Fever and Persistent Lung Infiltrate
    Tajender S. Vasu, Rodrigo Cavallazzi, Amyn Hirani, Paul Ellis Marik · 2009 · Respiratory Care
  51. The Nucleocapsid Protein of SARS-CoV Induces Transcription of hfgl2 Prothrombinase Gene Dependent on C/EBP Alpha
    Meifang Han, Wei Yan, Yufeng Huang, H. Yao, Zhi Wang, Xi Dong, Wen‐Zhu Li, Ye Zhou, Jinlin Hou, X. Luo et al. · 2008 · The Journal of Biochemistry
  52. Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy
    Kan Yonemori, Koji Tsuta, Chikako Shimizu, Yutaka Hatanaka, Kaoru Hashizume, Makiko Ono, Tsutomu Kouno, Masashi Ando, Kenji Tamura, Noriyuki Katsumata et al. · 2008 · Medical Oncology
  53. The bullseye sign: A variant of the reverse halo sign in COVID-19 pneumonia
    Thomas A. McLaren, James F. Gruden, Daniel B. Green · 2020 · Clinical Imaging
  54. Progressive and nonresolving pneumonia
    Donald E. Low, Tony Mazzulli, Tom J. Marrie · 2005 · Current Opinion in Internal Medicine
  55. Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis
    Shereen Farghaly, Mohammed Badedi, Rehab Ibrahim, Murad H. Sadhan, Asma Khalid Alamoudi, Awaji Alnami, Abdulrahman Muhajir · 2022 · Medicine
  56. Studies of Severe Acute Respiratory Syndrome Coronavirus Pathology in Human Cases and Animal Models
    Noriyo Nagata, Naoko Iwata‐Yoshikawa, Fumihiro Taguchi · 2010 · Veterinary Pathology
  57. Histopathological features in fatal COVID-19 acute respiratory distress syndrome
    Hamid Merdji, Sylvain Mayeur, M. Schenck, Walid Oulehri, Raphaël Clère-Jehl, Sibylle Cunat, J.-É. Herbrecht, R. Janssen-Langenstein, Alina Nicolae, Julie Helms et al. · 2021 · Medicina Intensiva (English Edition)
  58. Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients
    Polina Len, Gaukhar Iskakova, Zarina Sautbayeva, Aigul Kussanova, Ainur Tauekelova, Madina Sugralimova, Anar S. Dautbaeva, Meruert M. Abdieva, Eugene D. Ponomarev, Alexander Tikhonov et al. · 2022 · Frontiers in Cardiovascular Medicine
  59. High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19
    Yanjun Song, Peng Gao, Tian Ran, Hao Qian, Fan Guo, Long Chang, Wei Wu, Shuyang Zhang · 2020 · Frontiers in Cardiovascular Medicine
  60. Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia
    Mario Fonseca, Ross S. Summer, Jesse Roman · 2020 · The American Journal of the Medical Sciences
  61. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis
    Sarah Seeherman, Yuichiro Suzuki · 2021 · International Journal of Molecular Sciences
  62. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
    Annalisa Noce, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, Cristina Guerriero, Agostino Paolino, Giuseppa Pizzenti, Francesca Di Daniele et al. · 2021 · Pharmaceuticals
  63. Potential biomarkers for the early prediction of SARS-COV-2 disease outcome
    Vignesh Mariappan, P. S. Manoharan, Pajanivel Ranganadin, S. Lokesh, S. R. Rao, Agieshkumar Balakrishna Pillai · 2021 · Microbial Pathogenesis
  64. Successful treatment of suspected organizing pneumonia in a patient with Middle East respiratory syndrome coronavirus infection: a case report
    Insu Kim, Jeong Eun Lee, Kye‐Hyung Kim, Shinwon Lee, Kwangha Lee, Jeongha Mok · 2016 · Journal of Thoracic Disease
  65. Pathophysiology of acute fibrinous and organizing pneumonia – Clinical and morphological spectra
    Cláudia Santos, Rui Caetano Oliveira, Paula Serra, João Pedro Baptista, Eduardo Acácio de SOUSA, Paula Casanova, Jorge Pimentel, Lina Carvalho · 2019 · Pathophysiology
  66. Acute Lung Injury
    Oi-Yee Cheung, Paolo Graziano, Maxwell Lawrence Smith · 2017 · Elsevier eBooks
  67. Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID ‐19
    Ryutaro Arita, Rie Ono, Natsumi Saito, Shin Takayama, Takao Namiki, Takashi Ito, Tadashi Ishii · 2020 · Traditional & Kampo Medicine
  68. Fatal Coronavirus Disease 2019-associated Pulmonary Aspergillosis; A Report of Two Cases and Review of the Literature
    Shiema Abdalla, Muna A. Rahman S. AlMaslamani, Samar Mahmoud A Hashim, Abdulsalam Saif Ibrahim, Ali Senosi Omrani · 2020 · IDCases
  69. Correlation of autopsy pathological findings and imaging features from 9 fatal cases of COVID-19 pneumonia
    Lingyun Zhao, Xi Wang, Ying Xiong, Yanqing Fan, Yiwu Zhou, Wenzhen Zhu · 2021 · Medicine
  70. Acute lung injury—from cannabis to COVID
    Mary Beth Beasley · 2021 · Modern Pathology
  71. Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19
    Dana Rose Julian, Megan A. Kazakoff, Akhil Patel, Jesse M. Jaynes, Monte S. Willis, Cecelia Chrsitina Yates · 2021 · Current Pathobiology Reports
  72. Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report
    Flora Schein, Héloïse Munoz-Pons, Caroline Mahinc, Rémi Grange, Pascal J. Cathébras, Pierre Flori · 2020 · Journal de Mycologie Médicale
  73. Seguimiento de los pacientes después de neumonía por COVID-19. Secuelas pulmonares
    Iván Chérrez-Ojeda, Laura Gochicoa‐Rangel, Antonio Salles-Rojas, Hans Mautong · 2021 · Revista Alergia México
  74. Nebulization of glutathione and N-Acetylcysteine as an adjuvant therapy for COVID-19 onset
    José Fábio Lana, Anna Vitória Santos Duarte Lana, Quézia Souza Rodrigues, Gabriel Silva Santos, Riya Navani, Annu H. Navani, Lucas Furtado da Fonseca, Gabriel Ohana Marques Azzini, Thiago Setti, Tomas Mosaner et al. · 2021 · Advances in Redox Research
  75. Fatal acute fibrinous and organizing pneumonia in an infant: The histopathologic variability of acute respiratory distress syndrome
    Domenic R. Cincotta, Neil James Sebire, Emma J. Lim, Mark John Peters · 2007 · Pediatric Critical Care Medicine
  76. Acute fibrinous and organising pneumonia
    C. Guimaraes, Inês Sanches, Carlos Gil Ferreira · 2012 · BMJ Case Reports
  77. The Relationship of Severe Acute Respiratory Syndrome Coronavirus with Avian and Other Coronaviruses
    Mark W. Jackwood · 2006 · Avian Diseases
  78. Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
    Obinna Tobechukwu Ezeokoli, Carolina Henritta Pohl · 2020 · South African Medical Journal
  79. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics
    Eleni Gavriilaki, Ioannis Eftychidis, Ioannis Papassotiriou · 2021 · Journal of Laboratory Medicine
  80. An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity
    Yamei Zhang, Siobhán Gargan, Yongxu Lu, Nigel J. Stevenson · 2021 · Viruses
  81. A Descriptive and Quantitative Immunohistochemical Study Demonstrating a Spectrum of Platelet Recruitment Patterns Across Pulmonary Infections Including COVID-19
    Phillip McMullen, Joseph H. Cho, Jonathan L Miller, Aliya Noor Husain, Peter Pytel, Thomas N Krausz · 2020 · American Journal of Clinical Pathology
  82. Organizing pneumonia and COVID-19: A report of two cases
    Joana Simões, Ana Rita Ferreira, Pedro Martins Almeida, Frederico Trigueiros, Armando Lopes Braz, João R. Inácio, Fábio Cota Medeiros, Sandra Bráz, António Pais de Lacerda · 2021 · Respiratory Medicine Case Reports
  83. Invasion of the alveolar-capillary barrier byAspergillusspp.: therapeutic and diagnostic implications for immunocompromised patients with invasive pulmonary aspergillosis
    William W. Hope · 2009 · Medical Mycology
  84. Metabolic Changes in SARS-CoV-2 Infection: Clinical Data and Molecular Hypothesis to Explain Alterations of Lipid Profile and Thyroid Function Observed in COVID-19 Patients
    Damiano D’Ardes, Ilaria Rossi, Benedetta Bucciarelli, Marco Allegra, Francesco Bianco, Bruna Sinjari, Michele Marchioni, Marta Di Nicola, Francesca Santilli, Maria Teresa Guagnano et al. · 2021 · Life
  85. Infection metallomics for critical care in the post‐COVID era
    Rutuja H. Patil, Dominika Luptáková, Vladimı́r Havlı́ček · 2021 · Mass Spectrometry Reviews
  86. Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors' reply
    Dennis McGonagle, James S. O’Donnell, Κassem Sharif, Paul Emery, Charlie Bridgewood · 2020 · The Lancet Rheumatology
  87. Organizing pneumonia following Covid19 pneumonia
    Georg‐Christian Funk, Caroline Nell, Wolfgang Pokieser, Birgit Thaler, Gernot Rainer, Arschang Valipour · 2021 · Wiener klinische Wochenschrift
  88. COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States
    Anastasia I. Wasylyshyn, G. Rostyslaw Wasylyshyn, Kathleen A. Linder, Marisa H. Miceli · 2021 · Mycopathologia
  89. Viral Infections of the Lung
    Sherif R. Zaki, Christopher D. Paddock · 2008 · Springer eBooks
  90. Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
    Natalie M. Kirk, Yu-Ying Liang, H. Ly · 2024 · Virulence
  91. COVID-19: Nanomedicine Uncovers Blood-Clot Mystery
    Amir Ata Saei, Shahriar Sharifi, Morteza Mahmoudi · 2020 · Journal of Proteome Research
  92. SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids
    Natalia Sasoni, Milton Rodriguez Müller, Graciela Posse, Jorge González, Florencia Leonardelli, Guillermo García‐Effrón · 2020 · Revista Iberoamericana de Micología
  93. Pulmonary Functions Assessment in Post-COVID-19 Pneumonia Cases by Spirometry
    Shital Vishnu Patil, Rajesh Patil, Gajanan Gondhali · 2023 · Journal of Applied Sciences and Clinical Practice
  94. Is Acute Fibrinous and Organizing Pneumonia the Expression of Immune Dysregulation?
    Sonia Labarinas, Fabienne Gumy‐Pause, Anne‐Laure Rougemont, Gabriela Maria Baerlocher, Elisabeth Oppliger Leibundgut, Naomi Azur Porret, Michela G. Schäppi, Constance Barazzone‐Argiroffo, Jakob Robert Passweg, Laura Merlini et al. · 2013 · Journal of Pediatric Hematology/Oncology
  95. Airway involvement in interstitial lung disease
    Carlos Robalo Cordeiro · 2006 · Current Opinion in Pulmonary Medicine
  96. Imaging in the COVID-19 era: Lessons learned during a pandemic
    Georgios Antonios Sideris, Melina Nikolakea, Aikaterini-Eleftheria Karanikola, Sofia Konstantinopoulou, Dimitrios Giannis, Lucy E. Modahl · 2021 · World Journal of Radiology
  97. Antifungal Drug Susceptibility and Genetic Characterization of Fungi Recovered from COVID-19 Patients
    Milena Kordalewska, Kevin D. Guerrero, Rocio Garcia‐Rubio, Cristina Jiménez‐Ortigosa, José R. Mediavilla, Marcus H. Cunningham, Frank Hollis, Tao Hong, Kar Fai Chow, Barry N. Kreiswirth et al. · 2021 · Journal of Fungi
  98. Anticoagulation in COVID-19: a review of current literature and guidelines
    Bharat Narasimhan, Marta Lorente Ros, Jose S. Aguilar-Gallardo, Christopher Perez Lizardo, Harish Narasimhan, Celia Morton, Kevin R. Donahue, Wilbert S. Aronow · 2021 · Hospital Practice
  99. The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings in Mouse Models of SARS-CoV-2, Influenza A and Gammaherpesvirus Infections
    Simon De Neck, Rebekah Penrice-Randal, Jordan J. Clark, Parul Sharma, Eleanor G. Bentley, Adam Kirby, Daniele F. Mega, Ximeng Han, Andrew Owen, Julian A. Hiscox et al. · 2023 · Viruses
  100. Autopsy findings of pediatric COVID-19: a systematic review
    Gilbert Sterling Octavius, Jeremiah Hilkiah Wijaya, Alexa Ovilia Tan, Michelle Patricia Muljono, Shally Chandra, Andry Juliansen · 2022 · Egyptian Journal of Forensic Sciences